1,387 results on '"Kaikita, Koichi"'
Search Results
102. A Randomized, Double-Blind Comparison Study of Royal Jelly to Augment Vascular Endothelial Function in Healthy Volunteers
103. Increased thrombogenicity is associated with revascularization outcomes in patients with chronic limb-threatening ischemia
104. Impact of CYP2C19 polymorphism on clinical outcome following coronary stenting is more important in non-diabetic than diabetic patients
105. Correlation Between Extent of Myocardial Fibrosis Assessed by Cardiac Magnetic Resonance and Cardiac Troponin T Release in Patients With Nonischemic Heart Failure
106. Impact of CYP2C19 Polymorphism and Proton Pump Inhibitors on Platelet Reactivity to Clopidogrel and Clinical Outcomes Following Stent Implantation
107. Comprehensive analysis of intravascular ultrasound and angiographic morphology of culprit lesions between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome
108. Clinical significance of brachial–ankle pulse-wave velocity in patients with heart failure with preserved left ventricular ejection fraction
109. Clinical Usefulness of Dual-Energy Cardiac Computed Tomography in Acute Coronary Syndrome Using a Dual-Layer Spectral Detector Scanner
110. Abstract 21202: 5-Aminolevulinic Acid Combined With Sodium Ferrous Citrate Ameliorates Post Cardiac Ischemia/Reperfusion Injury via Regulating Inflammatory Cytokines
111. Abstract 19430: Combination of Two Different Microchips in Total Thrombus-Formation Analysis System Predicts High Risk Patients With Periprocedural Bleeding Events Events After Percutaneous Coronary Intervention
112. Abstract 19407: The Utility of IVUS-Guided PCI Especially in Terms of Mortality in a Community Based Data: In Acute Coronary Syndrome From Japanese Multicenter (KICS) Registry
113. Abstract 18049: The Relation Between Coronary Endothelial Dysfunction and High Platelet Aggregability
114. Abstract 17476: Optimal Predictors for Periprocedural Bleeding Events After Catheter Ablation for Atrial Fibrillation - Comparison of Total Thrombus-Formation Analysis System (T-TAS) and Plasma DOACs Concentration
115. Abstract 17203: The Prognostic Value of Serum Potassium Levels in Patients With Heart Failure (HF) With Preserved Left Ventricular (LV) Ejection Fraction (HFpEF)
116. Abstract 17142: Clinical Significance of Reactive Oxygen Metabolites in Heart Failure (HF) With Reduced Left Ventricular Ejection Fraction (HFrEF) Patients
117. Abstract 15275: Non Val30met Mutation, Septal Hypertrophy and Delayed Heart/Mediastium Ratio Are Useful Predictors of Poor Clinical Outcome in Japanese Patients With Hereditary Transthyretin Amyloidosis
118. Abstract 15110: Identification of the Characteristic Collateral Source in Patients With Arteriosclerosis Obliterans
119. Coronary plaque component in patients with vasospastic angina: A virtual histology intravascular ultrasound study
120. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients
121. Fragmented QRS complex is a diagnostic tool in patients with left ventricular diastolic dysfunction
122. Clinical characteristics and intravascular ultrasound findings of culprit lesions in elderly patients with acute coronary syndrome
123. High serum levels of thrombospondin-2 correlate with poor prognosis of patients with heart failure with preserved ejection fraction
124. Malnutrition-associated high bleeding risk with low thrombogenicity in patients undergoing percutaneous coronary intervention
125. Aberrant Expression of Cardiac Troponin-T in Lung Cancer Tissues in Association With Pathological Severity
126. Myocardial Tissue Characterization by Combining Extracellular Volume Fraction and T2 Mapping
127. Coronary Microvascular Dysfunction and Diastolic Load Correlate With Cardiac Troponin T Release Measured by a Highly Sensitive Assay in Patients With Nonischemic Heart Failure
128. Lack of association between peri-procedural myocardial damage and CYP2C19 gene variant in elective percutaneous coronary intervention
129. Usefulness of Sum of ST-Segment Elevation on Electrocardiograms (Limb Leads) for Predicting In-Hospital Complications in Patients With Stress (Takotsubo) Cardiomyopathy
130. Stratifying Bleeding Risk and Beyond ― Predicting Where Bleeding Will Occur ―
131. Increased soluble programed cell death-ligand 1 is associated with acute coronary syndrome
132. HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fraction
133. Hypercholesterolemia and hypoadiponectinemia are associated with necrotic core-rich coronary plaque
134. Determination of cut-off levels for on-clopidogrel platelet aggregation based on functional CYP2C19 gene variants in patients undergoing elective percutaneous coronary intervention
135. Sirt7 Deficiency Attenuates Neointimal Formation Following Vascular Injury by Modulating Vascular Smooth Muscle Cell Proliferation
136. Abstract 9477: Relation Between Coronary Artery Calcium Score and Clinical Outcomes After Percutaneous Coronary Intervention in Stable Coronary Artery Disease
137. Abstract 9903: CT Number Predicts Calcium Thickness in Optical Coherence Tomography Guided Percutaneous Coronary Intervention
138. Lotus Root-Like Appearance of a Lipid-Rich Plaque in a Patient With Acute Myocardial Infarction ― Findings From Near-Infrared Spectroscopy and Optical Coherence Tomography ―
139. Takotsubo cardiomyopathy after vaccination for coronavirus disease 2019 in a patient on maintenance hemodialysis
140. Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting
141. Intravascular ultrasound morphology of culprit lesions and clinical demographics in patients with acute coronary syndrome in relation to low-density lipoprotein cholesterol levels at onset
142. Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease
143. Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts
144. Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis.
145. Clinical factors affecting serum potassium concentration in cardio-renal decompensation syndrome
146. Resonant cardiac chamber with diastolic thrill
147. Paradoxical increase in E/e′ ratio after treatment of heart failure in two patients with preserved ejection fraction
148. Improvement of Vascular Endothelial Function Reflects Nonrecurrence After Catheter Ablation for Atrial Fibrillation
149. HE4 Predicts Progressive Fibrosis and Cardiovascular Events in Patients With Dilated Cardiomyopathy
150. Inhibitory Effect of Rivaroxaban on Atrial Arrhythmogenesis via Protease-Activated Receptor 2 Pathway
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.